The launch in the UK of Lurisidone began in August 2014.
My previous post on Lurasidone (Latuda) which is now been marketed in the UK followed the financial interests of one of the authors of the “Special article” in the British Journal of Psychiatry. 233 more words
Future pharmarchaeologists may try to unearth and analyze the sequence of events that triggered the eventual imposition of pharma price controls in the United States, for so long the bastion of pharmacoeconomic free enterprise. 637 more words